Katie Stuckey, OD
Optometrist · Oxford, MSNPI 1053935023
Payments from drug & device makers
Across 45 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$594
- Rxsight Inc$197
- Alcon$103
- Bausch & Lomb Americas Inc.$71
- Astellas Pharma US Inc$29
- Sun Pharmaceutical Industries Inc.$26
- plus $88 from 5 others
What the payments were for
- Speaking & faculty fees$262%
- Food & beverage$1,08498%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 27 | $594 |
| Rxsight Inc | 5 | $197 |
| Alcon | 5 | $103 |
| Bausch & Lomb Americas Inc. | 1 | $71 |
| Astellas Pharma US Inc | 1 | $29 |
| Sun Pharmaceutical Industries Inc. | 1 | $26 |
| Oyster Point Pharma, Inc. | 1 | $24 |
| Coopervision Inc. | 1 | $18 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $16 |
| Johnson & Johnson Vision Care, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
How this compares
$1,109 in reported general payments places this provider in the 60th percentile of 372 optometrist providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 14 | $14,813 |
| Cyclosporine | 17 | $7,579 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 27 | $1,395 |
| Prednisolone Acetate | 33 | $1,188 |
| Fluorometholone | 11 | $816 |
| Timolol Maleate | 20 | $367 |
| Latanoprost | 27 | $294 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 11 | $80 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Oxford
- Eric RandleOxford$3K
- Ryan WallyOxford$3K
- William StricklandOxford$3K
- Kristopher MayColdwater$263K
- Alyssa MabrySenatobia$66K
- Eleanor NullHernando$20K
- Roya AttarJackson$19K
- Deandre CarrByram$9K
- Michael ObrienSouthaven$9K
- George MarchbanksGulfport$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.